Richard Newitter Stock Analyst Profile - Truist Securities Research Coverage - Stocknear

Richard Newitter

Stock Analyst at Truist Securities

(4.2)
# 1822
Out of 5,504 analysts
447
Total ratings
Success rate
Average return

42 Stocks

Name Action PT Current % Upside Ratings Updated
BSX Boston Scientific
Maintains: Strong Buy
125 129
97.25 32.65% 18 Oct 1, 2025
GKOS Glaukos
Maintains: Buy
126 120
87.39 37.32% 6 Sep 22, 2025
BBNX Beta Bionics
Maintains: Strong Buy
21 28
22.25 25.84% 3 Sep 22, 2025
TMCI Treace Medical Conce...
Maintains: Hold
7 8
6.36 25.79% 15 Sep 4, 2025
MDT Medtronic
Maintains: Hold
92 96
97.73 -1.77% 16 Aug 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
111 63
53.83 17.04% 19 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
190 125
76.35 63.72% 26 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
410 415
370.49 12.01% 20 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
145 137
105.12 30.33% 8 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
81 82
77.08 6.38% 19 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
590 600
452.25 32.67% 29 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Hold
24
14.75 62.71% 1 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
102
67.06 52.1% 1 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
365
308.85 18.18% 1 Jun 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
80 68
60.5 12.4% 27 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
140 137
130.85 4.7% 37 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 70
36.02 94.34% 14 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
61 51
32.46 57.12% 3 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 24
18.76 27.93% 10 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 19
14.82 28.21% 18 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
111 145
175.55 -17.4% 16 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
118 113
100.78 12.13% 32 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
240 285
256.86 10.96% 5 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
7 5
n/a n/a 11 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 63
n/a n/a 15 Dec 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
48 51
n/a n/a 7 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 21
14.5 44.83% 1 Jan 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
12 7
n/a n/a 3 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 80
n/a n/a 3 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
30 31
n/a n/a 3 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
8.8 127.27% 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
71 82
77.27 6.12% 5 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
29
n/a n/a 11 Aug 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
260 250
193.93 28.91% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 110
n/a n/a 5 May 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 26
4.3 504.65% 4 May 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
690 770
132.25 482.23% 10 Apr 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
94 85
68.22 24.6% 6 Apr 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
12.17 64.34% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
23 27
17.87 51.09% 5 Feb 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 32
n/a n/a 6 Jun 21, 2018